Reproducible research practices, transparency, and open access data in the biomedical literature, 2015-2017
- PMID: 30457984
- PMCID: PMC6245499
- DOI: 10.1371/journal.pbio.2006930
Reproducible research practices, transparency, and open access data in the biomedical literature, 2015-2017
Abstract
Currently, there is a growing interest in ensuring the transparency and reproducibility of the published scientific literature. According to a previous evaluation of 441 biomedical journals articles published in 2000-2014, the biomedical literature largely lacked transparency in important dimensions. Here, we surveyed a random sample of 149 biomedical articles published between 2015 and 2017 and determined the proportion reporting sources of public and/or private funding and conflicts of interests, sharing protocols and raw data, and undergoing rigorous independent replication and reproducibility checks. We also investigated what can be learned about reproducibility and transparency indicators from open access data provided on PubMed. The majority of the 149 studies disclosed some information regarding funding (103, 69.1% [95% confidence interval, 61.0% to 76.3%]) or conflicts of interest (97, 65.1% [56.8% to 72.6%]). Among the 104 articles with empirical data in which protocols or data sharing would be pertinent, 19 (18.3% [11.6% to 27.3%]) discussed publicly available data; only one (1.0% [0.1% to 6.0%]) included a link to a full study protocol. Among the 97 articles in which replication in studies with different data would be pertinent, there were five replication efforts (5.2% [1.9% to 12.2%]). Although clinical trial identification numbers and funding details were often provided on PubMed, only two of the articles without a full text article in PubMed Central that discussed publicly available data at the full text level also contained information related to data sharing on PubMed; none had a conflicts of interest statement on PubMed. Our evaluation suggests that although there have been improvements over the last few years in certain key indicators of reproducibility and transparency, opportunities exist to improve reproducible research practices across the biomedical literature and to make features related to reproducibility more readily visible in PubMed.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Baker M. 1,500 scientists lift the lid on reproducibility. Nature. 2016;533(7604):452–4. 10.1038/533452a . - DOI - PubMed
-
- Wallach JD, Gonsalves GS, Ross JS. Research, regulatory, and clinical decision-making: the importance of scientific integrity. J Clin Epidemiol. 2017. Epub 2017/10/16. 10.1016/j.jclinepi.2017.08.021 . - DOI - PubMed
-
- Ioannidis JP. How to make more published research true. PLoS Med. 2014;11(10):e1001747 10.1371/journal.pmed.1001747 ; PubMed Central PMCID: PMC4204808. - DOI - PMC - PubMed
-
- Ioannidis JP, Greenland S, Hlatky MA, Khoury MJ, Macleod MR, Moher D, et al. Increasing value and reducing waste in research design, conduct, and analysis. Lancet. 2014;383(9912):166–75. 10.1016/S0140-6736(13)62227-8 ; PubMed Central PMCID: PMC4697939. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
